CLARITY - Safety and Efficacy of Oral Cladribine in Subjects With Relapsing-Remitting MS - Related Studies

CLARITY - Safety and Efficacy of Oral Cladribine in Subjects With Relapsing-Remitting MS

This study is ongoing, but not recruiting participants.

Study NCT00213135. Last updated on September 29, 2008. Information provided by EMD Serono

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Multiple Sclerosis
		Multiple Sclerosis, Relapsing-Remitting
		Sclerosis

2	More general conditions related to this trial
		Autoimmune Diseases
		Autoimmune Diseases of the Nervous System
		Demyelinating Autoimmune Diseases, CNS
		Demyelinating Diseases
		Immune System Diseases
		Nervous System Diseases
		Pathologic Processes

3	Interventions listed in this trial
		Cladribine
		Placebo

4	More general drug interventions related to this trial
		Antineoplastic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

5	Sponsors listed in this trial
		EMD Serono